New antiretroviral drugs

This publication has 25 references indexed in Scilit:

• Dose Range Study of Pharmacokinetics, Safety, and Preliminary Antiviral Activity of Emtricitabine in Adults with Hepatitis B Virus Infection
  Antimicrobial Agents and Chemotherapy, 2002
• British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy
  HIV Medicine, 2001
• Mechanism of Action of 1-β- d -2,6-Diaminopurine Dioxolane, a Prodrug of the Human Immunodeficiency Virus Type 1 Inhibitor 1-β- d -Dioxolane Guanosine
  Antimicrobial Agents and Chemotherapy, 2001
• Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients
  The Journal of Infectious Diseases, 2000
• New French guidelines for antiretroviral treatment
  HIV Medicine, 2000
• Mechanistic studies show that (−)‐FTC‐TP is a better inhibitor of HIV‐1 reverse transcriptase than 3TC‐TP
  The FASEB Journal, 1999
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
  AIDS, 1997
• Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
  Proceedings of the National Academy of Sciences, 1993
• Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
  Antimicrobial Agents and Chemotherapy, 1992